GnRH Therapy on Cognition in Down Syndrome
NCT04390646
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
RECRUITING
Status
56
Enrollment
OTHER
Sponsor class
Conditions
Down Syndrome
Cognitive Decline
Alzheimer Disease, Early Onset
Olfaction Disorders
Interventions
DRUG:
GnRH, gonadorelin acetate
DRUG:
0.9% NaCl
Sponsor
Nelly Pitteloud